STAT3 and prostate carcinoma: More precisely, osteolytic lesions of human prostate cancer show enriched pAKT levels in the tumor area and associated macrophages, whereas osteoblastic lesions were shown to possess higher phospho-signal transducer and activator of transcription 3 (pSTAT3) levels [104].